share_log

Hypera (OTCMKTS:HYPMY) Upgraded at The Goldman Sachs Group

Hypera (OTCMKTS:HYPMY) Upgraded at The Goldman Sachs Group

高盛集團對Hypera（OTCMKTS: HYPMY）進行了升級
Financial News Live ·  2022/10/21 14:31

The Goldman Sachs Group upgraded shares of Hypera (OTCMKTS:HYPMY – Get Rating) from a neutral rating to a buy rating in a research report released on Monday, The Fly reports.

高盛集團上調了股票 Hypera (OTCMKTS: HYPMY — 獲取評級) The Fly報道，在週一發佈的研究報告中，從中性評級到買入評級。

Hypera Trading Up 1.4 %

Hypera 交易量上漲1.4％

Hypera stock opened at $9.34 on Monday. The business's 50-day simple moving average is $8.47 and its 200-day simple moving average is $7.98. Hypera has a 52 week low of $4.63 and a 52 week high of $9.37.

Hypera股票週一開盤價爲9.34美元。該公司的50天簡單移動平均線爲8.47美元，其200天簡單移動平均線爲7.98美元。Hypera的52周低點爲4.63美元，創下52周高點9.37美元。

Get
得到
Hypera
Hypera
alerts:
警報：

Hypera Company Profile

Hypera 公司簡介

(Get Rating)

（獲取評級）

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA作爲一家制藥公司在巴西運營。它提供 Adacne、Addera、apri、AmpliumG 下的處方產品，請 Celestamine、Celestone、Celestone Soluspan、Cizax、diciprax、Dirmotil Fusid、Digedrat、diprosalic、diprosone、diprosone、diprosalic、diprosone、diprosone、Diprosan、Emprol XR、Flow、Garasone、Halobex、Librox panon、moon、Lydian、macrodantin、maxSulid、milgamma、Mioflex — A、nesina、Novotram、oximax、predal、pressaliv、Quadridem、Rizi M、softalm、tacroz、tinodin、umma 和 velunid 品牌。

Featured Articles

精選文章

  • Get a free copy of the StockNews.com research report on Hypera (HYPMY)
  • Is it Time to Snack on Mondelez Stock?
  • Freeport McMoran Shares Rally Despite Weakening Copper Prices
  • Will Matador Share Price Get A Boost From Improved Credit Rating?
  • Tesla Stock Slides After Revenue Miss, Musk Maintains Optimism
  • AT&T Jumps Higher Thursday After Better-Than-Expected Q3 Results
  • 免費獲取 StockNews.com 關於 Hypera (HYPMY) 的研究報告的副本
  • 是時候在 Mondelez 的股票上喫零食了嗎？
  • 儘管銅價疲軟，弗裏波特麥克莫蘭股價仍上漲
  • 信用評級的提高會提振鬥牛士的股價嗎？
  • 收入下降後，特斯拉股價下滑，馬斯克保持樂觀情緒
  • 在第三季度業績好於預期之後，AT＆T週四上漲

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Hypera Daily 的新聞和收視率 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Hypera及相關公司最新新聞和分析師評級的簡明每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論